Challenger Limited (ASX:CGF) has disclosed that its Board has rejected a revised non-binding and conditional indicative offer from TAL Daiichi Life Australia Pty Limited to acquire the remaining 79.5% of ordinary shares in Challenger it does not already own at a price of $12.20 per share, stating the offer does not adequately represent fair value for Challenger shareholders in the context of a control transaction.
Key Points
- TAL Daiichi Life Australia Pty Limited submitted a revised non-binding and conditional indicative offer to acquire the remaining 79.5% of Challenger ordinary shares it does not already own at $12.20 per share.
- The Challenger Board, having obtained advice from financial and legal advisers, determined the Revised Offer does not adequately represent fair value for shareholders in the context of a control transaction.
- The Revised Offer follows prior engagement between the companies referenced in Challenger's update on 26 October 2026.
- Challenger shareholders do not need to take any action in relation to the Revised Offer.
Terms of the Revised Non-Binding Offer
According to the filing dated 19 November 2026, TAL Daiichi Life Australia Pty Limited submitted a revised non-binding and conditional indicative offer to acquire the remaining 79.5% of ordinary shares in Challenger that TDA does not already own. The offer price disclosed in the filing is $12.20 per share. The filing states the Revised Offer follows engagement between the two companies, as noted in Challenger's earlier market update on 26 October 2026. The offer is described as non-binding and conditional.
Board's Assessment of the Revised Offer
The Challenger Board disclosed it carefully considered the terms of the Revised Offer, including obtaining advice from its financial and legal advisers. Following that process, the Board concluded that the Revised Offer does not adequately represent fair value for Challenger shareholders in the context of a control transaction. The filing does not disclose further details of the advice received or the specific basis on which fair value was assessed. The release was authorised by Challenger's Continuous Disclosure Committee.
Shareholder Action and Ongoing Disclosure
The filing states that Challenger shareholders do not need to take any action in relation to the Revised Offer. Challenger confirmed it will continue to keep the market informed in accordance with its continuous disclosure obligations. No timetable for further developments was disclosed in the filing. Challenger is described in the filing as Australia's leading retirement income business, established in 1985, operating an APRA-regulated life company and listed on the Australian Securities Exchange.



Please wait processing your request...